Generic Peptides Somatropin 100 to 200 IU HGH Kits for Sale
Out of stock
Injection · 2 mg · vial
Generic Peptides CJC-1295 no DAC is modified GRF (1-29), a short-acting GHRH analog supplied as a lyophilized research powder in three vial sizes: 2 mg, 5 mg and 10 mg.
GMP-manufactured, each batch is HPLC-verified with the Certificate of Analysis on file. CJC-1295 no DAC for sale with international shipping and fast dispatch within two to three business days.
Generic Peptides CJC-1295 no DAC is modified GRF (1-29), a short-acting GHRH analog sold as a lyophilized research powder. Without the complex that anchors CJC-1295 DAC to albumin, it is studied as a sharp pulse, not a flat signal.
All three vials hold the same peptide, so the choice is how much material one series needs.
| Variant | Dosage | Form and quantity | Best use |
|---|---|---|---|
| CJC-1295 no DAC 2 mg | 2 mg | Lyophilized vial | Short runs |
| CJC-1295 no DAC 5 mg | 5 mg | Lyophilized vial | Standard runs |
| CJC-1295 no DAC 10 mg | 10 mg | Lyophilized vial | Extended runs |
The 10 mg vial covers an extended series and the 2 mg vials a short one. A ghrelin-driven pulse from GHRP-2 or Ipamorelin is the usual research partner.
The chain carries four substitutions that slow breakdown by DPP-4. It binds GHRH receptors on the pituitary, which releases growth hormone in a pulse, and the liver answers with IGF-1. Research summaries put its half-life near 30 minutes, against six to eight days for DAC.
Dissolve the powder with sterile or bacteriostatic water, which is not included, adding it down the vial wall and swirling. Divide the milligrams on the vial by the millilitres added to read mg per mL. Keep the powder at 2-8 C or -20 C and the mixed solution at 2-8 C for about four weeks.
No approved dose exists for this peptide, and the 2006 human program tested only the DAC version, so the short-acting form has no human dosing data. CJC-1295 is named in WADA class S2 and banned in sport at all times. Related compounds are Sermorelin and Somatropin.
Supplied for laboratory research only, not for human or veterinary use. Information provided is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before use.
| Trade Name | CJC-1295 no DAC |
| Generic Name | Modified GRF (1-29) |
| Manufacturer | Generic Peptides |
| Dosage | 2 mg, 5 mg or 10 mg per vial |
| Package | Lyophilized powder, one vial |
| Drug Class | Peptide hormone; GHRH analog |
| Administration | Subcutaneous (research protocols) |
| Storage | Lyophilized 2-8 C or -20 C; mixed 2-8 C, 4 weeks |
| Prescription Status | Research use only |
| Verification | Batch details confirmed with supplier |
| Shipping | International, about USD 35; no USA option |
For laboratory research only. Consult a healthcare professional before handling any peptide. Amounts shown are research references, not recommended human doses.
Before you ask
It is modified GRF (1-29), a 29 amino acid analog of growth hormone releasing hormone. The chain keeps four substitutions that resist enzyme breakdown but drops the drug affinity complex, the linker that binds the DAC version to albumin. That one difference makes it short-acting, so it is used in research on pulsatile growth hormone release rather than a long signal.
Add sterile or bacteriostatic water down the side of the vial and swirl it, do not shake. Divide the milligrams printed on the vial by the millilitres you added to get mg per mL, so a 5 mg vial with 2 mL gives 2.5 mg/mL. Keep the solution at 2-8 C and use it within about four weeks, and never freeze it.
Keep the powder cold, dry and out of light. Suppliers recommend 2-8 C for routine handling and -20 C for long-term storage. Peptides are hygroscopic, so let the sealed vial reach room temperature before opening it, then reseal it tightly. Once the powder is dissolved, refrigeration at 2-8 C is needed.
The DAC version carries a maleimidopropionyl group that attaches the peptide to plasma albumin, and published work puts its half-life at about six to eight days. The no DAC chain has no such anchor and clears in minutes, roughly 30 minutes in research summaries. One gives a long flat rise, the other a short pulse.
No human safety data exists for this exact short-acting form, because the clinical program that reached phase two used the DAC version and was stopped in 2006 after a participant died. Reported effects of the class include injection-site reactions, headache, flushing and changes in appetite or blood sugar.
Yes. The WADA Prohibited List 2026 names CJC-1295 in class S2.2.4, growth hormone releasing factors, and substances in that class are prohibited in and out of competition. The listing covers GHRH and its analogues, so it applies to the no DAC chain as well as the long-acting version.
All three vial sizes are listed on this page as lyophilized research material with international shipping at checkout. Shipping is about 35 dollars, orders are handled in one to two days and transit takes four to ten days to the countries listed at checkout. Check the import rules where you live before ordering.
Be the first to share your experience with Generic Peptides CJC-1295 no DAC 2 to 10 mg Research Vials
Log in to write a reviewComplete the cycle
Out of stock
Out of stock
Out of stock